JENBURKT PHARMACEUTICALS
Back to Income Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹169 Cr | ₹152 Cr | ₹142 Cr | ₹137 Cr | ₹124 Cr |
What is the latest Revenue of JENBURKT PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹169 Cr |
| Mar2025 | ₹152 Cr |
| Mar2024 | ₹142 Cr |
| Mar2023 | ₹137 Cr |
| Mar2022 | ₹124 Cr |
How is Revenue of JENBURKT PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹169 Cr | 11.24 | |
| Mar2025 | ₹152 Cr | 6.85 | |
| Mar2024 | ₹142 Cr | 3.82 | |
| Mar2023 | ₹137 Cr | 10.30 | |
| Mar2022 | ₹124 Cr | - | |
Compare Revenue of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹395.7 Cr | -4.4% | 0.4% | -26.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -4.4% |
0.4% |
-26.7% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses